Application of LRG1 as serological marker for diagnosing thromboangiitis obliterans

The invention provides an application of LRG1 as a serological marker for diagnosing thromboangiitis obliterans, and an application of LRG1 as a serological marker for diagnosing inflammatory activitydegree of thromboangiitis obliterans. The application of the invention provides a new auxiliary judg...

Full description

Saved in:
Bibliographic Details
Main Authors DONG ZHIHUI, FANG YUAN, FANG GANG, FU WEIGUO, LIU HAO, PAN TIANYUE, JIANG XIAOLANG
Format Patent
LanguageChinese
English
Published 11.08.2020
Subjects
Online AccessGet full text

Cover

More Information
Summary:The invention provides an application of LRG1 as a serological marker for diagnosing thromboangiitis obliterans, and an application of LRG1 as a serological marker for diagnosing inflammatory activitydegree of thromboangiitis obliterans. The application of the invention provides a new auxiliary judgment means for early diagnosis and inflammation early warning of thromboangiitis obliterans, and the non-invasive diagnosis efficiency of thromboangiitis obliterans can be improved by combined application with other biomarkers. 本发明提供了LRG1作为诊断血栓闭塞性脉管炎的血清学标志物的应用,以及LRG1作为诊断血栓闭塞性脉管炎炎症活动程度的血清学标志物的应用。本发明的应用为血栓闭塞性脉管炎的早期诊断和炎症预警提供新的辅助判断手段,与其他生物学标志物联合应用可以提高血栓闭塞性脉管炎的非创伤诊断效率。
Bibliography:Application Number: CN202010311849